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The issue of whether multiple, ipsilateral or bilateral, breast carcinomas represent multiple primary tumours or dissemination of a
single carcinomatous process has been difficult to resolve, especially for individual patients. We have addressed the problem by
comparative genomic hybridisation analysis of 26 tumours from 12 breast cancer patients with multiple ipsilateral and/or bilateral
carcinoma lesions. Genomic imbalances were detected in 25 of the 26 (96%) tumours. Using the genomic imbalances detected in
these 26 lesions as well as those previously found by us in an independent series of 35 unifocal breast carcinomas, we compared a
probabilistic model for likelihood of independence with unsupervised hierarchical clustering methodologies to determine the clonal
relatedness of multiple tumours in breast cancer patients. We conclude that CGH analysis of multiple breast carcinomas followed by
unsupervised hierarchical clustering of the genomic imbalances is more reliable than previous criteria to determine the tumours’
clonal relationship in individual patients, that most ipsilateral breast carcinomas arise through intramammary spreading of a single
breast cancer, and that most patients with bilateral breast carcinomas have two different diseases.
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Breast cancer patients not rarely present multiple tumours (Lesser
et al, 1982; Anastassiades et al, 1993; Vaidya et al, 1996). The
increased emphasis in recent years on breast-sparing surgical
treatment (Holland et al, 1985; Fisher, 1992; Connolly et al, 1995)
has made it more clinically important to know whether multiple,
ipsilateral breast carcinomas represent several primary tumours
(multicentricity) or intramammary dissemination of a single
carcinomatous process (multifocality). The fundamental biological
interest of the issue is also profound, as it is also for bilateral breast
carcinomas (Dawson et al, 1991; Sterns and Fletcher, 1991): are
they two separate primary tumours or the metastasis from one
breast to the other? Several criteria have been suggested to
discriminate multiple primary tumours from metastatic lesions,
including different histological growth patterns, the presence of in
situ components in both tumours (for both ipsilateral and bilateral
lesions), and localisation in different quadrants or more than 5cm
apart (for ipsilateral tumours; Dawson et al, 1991, 1995; Sterns and
Fletcher, 1991; Dawson, 1993). However, the unspecific and
quantitative nature of these criteria makes a reliable assessment
of the competing hypotheses difficult in most cases.
A comparison of more fundamental biological characteristics
of the different tumours could conceivably provide more reliable
information as to whether they are clonally related or not.
Among the principles used have been X-inactivation analysis
(Noguchi et al, 1994a,b; Shibata et al, 1996), comparisons of
allelic imbalance patterns (Tsuda and Hirohashi, 1995; Imyanitov
et al, 2002), or the distribution of TP53 point mutations
(Ackerman et al, 1995; Kinoshita et al, 1995; Shibata et al, 1996),
but these studies depend heavily on statistical group comparisons
and therefore are of limited value in individual patients. We have
in the past successfully assessed the pathogenetic and clonal
relationships among multiple breast tumours by means of
chromosome banding analysis with karyotyping (Pandis et al,
1995; Teixeira et al, 1994, 1997). Since this technique provides
screening information about all chromosome-level abnormalities
that exist in individual cells, with each karyotypic change serving
as a separate clonality marker, it is in principle highly efficient for
the present purpose. However, because karyotyping is critically
dependent on the successful in vitro culture and cytogenetic
analysis of the separate cancer lesions, inadequate cell attachment,
low in vitro mitotic index, and poor technical quality of
chromosome preparations of the cells of the neoplastic parench-
yma (even if for only one of the lesions) may render the case
uninformative.
To circumvent the above-mentioned methodological limitations,
we have used comparative genomic hybridisation (CGH), a
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stechnique that is not dependent on obtaining tumour metaphases
while retaining the ability to detect copy number changes at all
chromosomes at the same time, to analyse 26 tumours from 12
breast cancer patients with multiple ipsilateral and/or bilateral
lesions. Furthermore, using the present data and those previously
found by us in a series of 35 unifocal breast carcinomas (Teixeira
et al, 2001), we have compared a probabilistic model for the
likelihood of independence and hierarchical clustering methodol-
ogies to determine the clonal relationship among the multiple
tumours in individual breast cancer patients.
MATERIAL AND METHODS
Tumour specimens
Samples from 26 macroscopically separate tumours arising in 12
women diagnosed with breast cancer were fresh frozen at  801C
until processed for DNA extraction. Four patients had ipsilateral
tumours and another seven women had bilateral tumours. The
12th patient presented both ipsilateral and bilateral tumours (two
in each breast) and had a history of radiotherapy for a mediastinal
lymphoma; no iatrogenic or other predisposing factors were
known for the other patients. The histopathologic classification of
each tumour was made in accordance with WHO recommenda-
tions (Sobin, 1981) and was based on examination of tissue
immediately adjacent to the samples processed for genetic
investigation (Table 1). The study was approved by the institu-
tional review board.
Comparative genomic hybridisation
The CGH procedure of Kallioniemi et al (1994) was performed
with modifications previously described by Teixeira et al (2001).
Briefly, test (tumour) and reference (peripheral blood lymphocytes
from a healthy female) DNA was extracted using standard methods
and labelled in nick-translation reactions using fluorochrome-
conjugated nucleotides, after which DNA fragment lengths
between 300 and 2000bp were obtained. Labelled tumour and
reference DNA was mixed with unlabelled Cot-1 DNA, ethanol-
precipitated, dried, and dissolved in hybridisation buffer. Normal
metaphases were obtained from commercially available prepara-
tions. After denaturing the chromosomes and the DNA probe,
hybridisation was allowed to occur for 2–3 days in a humidified
chamber at 371C. After a series of washes, the slides were mounted
in an antifade solution with DAPI.
A total of 10 good-quality metaphase spreads were selected for
analysis in each case. Three images, corresponding to each
fluorochrome and the DAPI counterstain, were sequentially
captured with a Cohu 4900 CCD (12-bit grey scale) camera, using
an automated filter wheel coupled to a Zeiss Axioplan fluorescence
microscope (Zeiss, Oberkochen, Germany) and a CytoVision
system with software version 2.7 (Applied Imaging, Santa Clara,
CA, USA). Chromosomes were identified based on their inverted
DAPI appearance, and the relative hybridisation signal intensity
was determined along each chromosome. Data obtained from the
10 cells were combined to generate average ratio profiles with 99%
confidence intervals for each chromosome. A negative (normal vs
normal) and a positive control were included in every set of
experiments. In all, 10 cells of each of 10 normal vs normal
hybridisations were used to establish the normal ratio profile with
99% confidence intervals (Kirchhoff et al, 1998). Copy number
gains or losses were scored whenever the test and reference 99%
confidence intervals did not overlap. The description of the CGH
copy number changes followed the guidelines suggested by the
ISCN (1995).
Probabilistic model of clonal relatedness
In order to evaluate the clonal relatedness between any two given
tumours present in the same breast cancer patient, we used the
probabilistic model described by Kuukasja ¨rvi et al (1997). A
common clonal origin of two tumours can be inferred if they share
a set of copy number gains and losses, not likely to be shared at
random. In short, if a1, a2, a3, and so forth are specific genomic
gains or losses, the probability of a particular abnormality
occurring is obtained by dividing the number of occurrences of
that change by the number of tumours analysed. If T1 is the set
copy number changes of one tumour and T2 the set of copy
number changes of another tumour, the events common to both
tumours are defined by T1 - T2¼c1, c2, c3,yck. Thus, a
conservative estimate of the probability of a particular set of
shared copy number changes occurring independently in two
tumours at random is p(c1)   p(c2)   p(c3)  y  p(ck)¼X.I f
two tumours share no genetic changes, X is by definition 1. A
measure of clonal relatedness between two tumours is 1 X, which
equals 0 if no changes are shared and approaches 1 if X is small.
According to this model, a clonal relationship between two
tumours can be inferred whenever Xo0.05 (clonal relatedness
40.95). The probabilities of each copy number change occurring
in each chromosome arm used in this probabilistic model were
those previously reported by us in a series of 37 unifocal breast
carcinomas (Teixeira et al, 2001), 35 of which were shown to
harbour genomic imbalances by CGH. Copy number gains or
losses at the same chromosome arm in different tumours of the
same patient were considered the same only if the respective
breakpoints did not differ by more than two bands.
Hierarchical clustering of CGH data
In order to code CGH data for use with clustering software, the
copy number findings were registered in an Excel spreadsheet by
each of two methods: by chromosome arm (41 data points) and by
chromosome band (302 data points; in both strategies excluding
the p arms of the acrocentric chromosomes). The codification of
copy number changes by band was carried out as follows: no
change, 0; gain, þ1; loss,  1; amplification (ratio 42), þ2. The
codification of copy number changes by chromosome arm was
carried out as follows: no change, 0; gain, þ1; loss,  1;
amplification, þ2; gain and loss from the same chromosome
arm,  2. Each spreadsheet was then saved as a tab-delimited text
file and loaded into the clustering software J-Express Pro
(Molmine, Bergen, Norway).
Unsupervised hierarchical clustering of genomic imbalances was
first performed with three pairs of primary breast carcinoma and
its respective lymph node metastasis displaying different degrees
of clonal relatedness (varying from 0.24–7 10
 9, calculated as
described above). Several software settings (including Eucledian
distance vs Pearson correlation as distance metric and single vs
complete linkage as cluster method) were tested to determine those
that gave the best hierarchical clustering of each pair of primary
tumour and lymph node metastasis (data not shown). The settings
selected for the rest of the analyses were complete linkage (cluster
method) and Pearson correlation (distance metric).
Besides coding the genomic imbalances separately by chromo-
some arm and by band, unsupervised hierarchical clustering
analysis was tested as an alternative way to measure clonal
relatedness among multiple breast tumours in two different ways.
First, the genomic imbalances of the tumours of each breast cancer
patient were compared with those of a previously reported series of
35 breast carcinomas with copy number changes (Teixeira et al,
2001). Second, the genomic changes of all 26 tumours of the 12
patients here reported were compared among themselves. The
dendograms thus obtained group the tumours with the highest
degree of genetic similarity in short-branched clusters, with longer
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sbranches indicating increasing genomic disparity. The clustering
apart of tumours from the same patient, indicating that they were
more similar with carcinomas of other patients than with one
another, was taken as evidence of clonal unrelatedness. The
clustering together of two tumours from the same woman
indicated clonal relatedness among them, whereas the clustering
of breast carcinomas from different women signified that they had
followed similar pathogenetic pathways.
RESULTS
Comparative genomic hybridisation
All but one tumour presented copy number changes by CGH
(Table 1). The number of imbalances per tumour ranged from 0
to 28 with an average of 8.2 per tumour. The number of copy
number gains varied from 0 to 15 (average: 3.5) and the losses
Table 1 Histopathology, genomic imbalances, and clonal relatedness of 26 ipsilateral and/or bilateral tumours from 12 breast cancer patients
Case no. Lab no. Tumour Diagnosis
a CGH X
b
Hierarchical
clustering
c
Clonal
relatedness
d
Ipsilateral
tumours
1 326A/92 A COM rev ish enh(1p22pter,1q22q24,2p23q12,3q,7p14p21,
8q21qter,9pterq33,18p11q12,18q22q23,20p11pter),
dim(Xp11p21,Xp22,4p16,4q34q35,5q12q14,6p24,
6p25,10p14p15,10q23,10q24qter,11q13qter,13q14q21,
13q33q34,15q24,16q22qter)
2 10
 4 CR
326B/92 B DCIS rev ish enh(3q24q29,8q21qter,9q22,20p12p13),
dim(10p15,11q13q22,11q23qter,22q13)
2 368A/92 A DC rev ish dim(1p34pter,8p22pter,15q13qter,16q,22q11qter) 0.26 UC UR
368B/92 B DCIS+EH rev ish enh(8p21qter,16p11pter),dim(6q14qter,8p22pter,9q22,17p12pter)
3 426A/92 A DC+DCIS rev ish enh(1q,7p11p21,16p),
dim(1p21pter,7q21qter,11q12q13,11q22qter,16q23qter,22q)
8 10
 5 CR
426B/92 B DC+DCIS rev ish enh(1q,7p,16p),dim(1p,7q21qter,11q12q13,11q21qter,16q23qter,22q)
4 522A/92 A DC rev ish enh(1q,5,8,16p11pter),dim(15q21q22,15q24q25,16q,22q) 0.002 C R
522B/92 B DC rev ish enh(1q,5,8,16p12,16p13),dim(16q)
Bilateral
tumours
5 197/92 Right DC rev ish enh(1q25q32,1q41) 1 UC UR
198/92 Left DC rev ish enh(1q23q43,8p11qter,9p),dim(8p21pter,9q21qter,16q)
6 307/92 Left DC+DCIS rev ish enh(1p31,1q23q42,3q26q27,6p21,6p23,8p12qter,12q15q21),
dim(8p21pter,11q21qter,13q,15q21q23,15q24q26,
16q,17p12pter,17q24q25,18p11)
0.09 UC UR
308/92 Right LC+LCIS rev ish enh(8p11p21),dim(8p23,16q21qter),amp(8p12)
7 375/92 Left LC+LCIS rev ish enh(8p12qter,16p),dim(9q13q31,10p12p14,11p14pter,11q22qter,
13q21qter,16q)
0.31 UC UR
376/92 Right LC+LCIS rev ish enh(Xp11p12,Xp22,Xq21qter,1q,7,14q, 15q11q25,16p11pter,20)
8 382/92 Left DC+DCIS rev ish enh(1q,5pterq35,7p13p14,7p15p21,7q11q33,16p11pter),dim(16q) 0.24 UC UR
383/92 Right DC+DCIS rev ish enh(1q22q43),dim(6p22,6q21q27,11q21qter,16q,22q12q13)
9 50/93 Left DC+DCIS rev ish enh(X,1q21qter,7pterq36,14q,16p,20),dim(10q) 1 UC UR
51/93 Right LC+LCIS rev ish enh(8q11q24.1),
dim(2p23pter,2q21q22,6q24q27,11q24qter,13q12q13,
13q31q33,16q23qter,18q22qter)
10 588/93 Left DC+DCIS rev ish enh(8p12qter,16p),dim(8p21pter,9q22,16q) 1 UC UR
589/93 Right DC+DCIS no changes
11 257/94 Left LC rev ish enh(1q),dim(6q14qter,16q,17p12pter,22q) 0.001 C R
258/94 Right LC rev ish enh(1q),dim(6q14q25,16q,17p13,22q)
Ipsilateral
and bilateral
tumours
12 17/97 Right A DC rev ish enh(8p11p12),
dim(3p21,5q31qter,6q16qter,8p22pter,13q12qter,14q32)
1 (0.37
e)U C U R
18/97 Right B DC rev ish enh(4q12q21)
19/97 Left A DC rev ish enh(1q21q41,15q21qter,16p11pter,17q23q25),
dim(3q21q25,5q14,6q14qter,8q12q21,10q24qter,
11p,11q14qter,12p11pter,14q24,22q12qter)
0.01 UC UR
20/97 Left B DC rev ish enh(1p13p34,1q,3p24pter,4p15q35,5p15q35,
7p21,7q11qter,8,10p11pter,16p11p13,17q12q21,17q23q25,18,20,21q),
dim(1p35pter,2,3p21qter,6q14q24,7p12p13,9q33qter,
10q,11p,11q23qter,13q,14q,16q21q24,17p12pter)
aCOM¼comedo carcinoma; DC¼ductal carcinoma; DCIS¼ductal carcinoma in situ;L C¼lobular carcinoma; LCIS¼lobular carcinoma in situ;E H¼epithelial hyperplasia.
bX,
probability of the shared genomic imbalances occurring just by chance (see Materials and methods).
cUnsupervised hierarchical clustering analysis based on chromosome-arm
coding of CGH copy number changes (see Materials and methods); C¼clustered; UC¼unclustered.
dClonal relatedness based on unsupervised hierarchical clustering analysis
of CGH data coded by chromosome arm; R¼related; UR¼unrelated.
eCalculation for comparing the two left and the two right tumours (both tumours of each side taken
together).
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sfrom 0 to 14 (average: 4.7). The chromosome arms from
which material was most frequently gained were 1q (62%), 16p
(46%), 8q (42%), proximal 8p (38%), and 7p (27%), whereas the
ones most often displaying losses were 16q (65%), 11q (38%), 22q
(35%), 6q (31%), and distal 8p and 13q (23% each). One tumour
showed genomic amplification (here defined as ratio above 2.0)
at 8p12.
Clonal relatedness by the probabilistic model
The probability that the separate tumours of the 12 breast cancer
patients share genomic imbalances just by chance is presented in
Table 1. Whenever this probability was less than 0.05, a clonal
relatedness between two tumours could be inferred with a
probability greater than 0.95. With this method, a clonal relation-
ship between the two tumours was found in three of four patients
with ipsilateral breast tumours (75%) and in one of seven patients
with bilateral breast carcinomas (14%). In the patient with both
ipsilateral and bilateral multiple breast tumours (case 12), clonal
relatedness was inferred between the two tumours in the left
breast, a finding that was not confirmed by hierarchical clustering
(see below).
Hierarchical clustering of CGH data
We first used unsupervised hierarchical clustering analysis of
genomic imbalances coded by chromosome arm to measure
clonal relatedness among multiple breast tumours. When the
copy number changes of the tumours of each breast cancer
patient were compared with those of a previously reported series of
35 breast carcinomas, a clonal relationship between the two
tumours was found in three of the four pairs of ipsilateral
breast tumours (Figure 1) and in one of seven pairs of bilateral
breast carcinomas (Figure 2; Table 1). The findings for these
11 patients were completely concordant with those obtained
with the probabilistic model described above. This was not so
for the patient with both ipsilateral and bilateral multiple breast
tumours, however, as hierarchical clustering indicated that all
four tumours were clonally unrelated. The clonal relationships
determined by hierarchical clustering of the chromosome arm
Figure 1 Comparative genomic hybridisation (A, B) and hierarchical clustering (C) of two ipsilateral breast tumours (case 1) together with 35 other
breast carcinomas with copy number changes (coded by chromosome arm). Green bars to the right and red bars to the left of the chromosome ideograms
indicate copy number gains and losses, respectively. See Table 1 for case numbers and a detailed description of the genomic imbalances. The two tumours
cluster together (asterisks), showing that they are clonally related (multifocal breast carcinomas).
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simbalances of all 26 tumours of the 12 patients here reported
(Figure 3) were in all cases similar to that obtained after
comparison of each patient with the separate series of breast
carcinomas.
When we used unsupervised hierarchical clustering analysis of
the genomic imbalances coded by chromosome band of all 26
tumours from the 12 breast cancer patients, the clonal relation-
ships thus determined were in all cases identical to those described
above with chromosome arm coding. The same was true for all but
one case when the copy number changes coded by chromosome
band present in the tumours of each of the 12 patients were
compared against the separate series of 35 breast carcinomas; the
exception was the apparent clonal relatedness between the two left
tumours of case 12.
DISCUSSION
Comparative genomic hybridisation revealed genomic imbalances
in 25 of the 26 (96%) breast tumours present in the 12 breast
cancer patients, underscoring the considerable potential of the
present methodology when it comes to determining the clonal
relatedness among two or more tumours in the same patient.
The overall pattern of copy number changes detected in this
series of 26 tumours does not differ significantly from that
previously found by us in a independent series of 37 breast cancer
patients (Teixeira et al, 2001), the most frequent genomic
imbalances being gain of 1q, 16p, 8q, proximal 8p, and 7p and
loss of 16q, 11q, 22q, 6q, distal 8p, and 13q. Some discrepancies,
such as the apparently increased frequency of 16q and 22q loss in
the present series, are probably due to the fact that some of the 26
tumours were not truly independent and the differences become
insignificant when only pathogenetically independent carcinomas
are considered.
One way to find out whether two ipsilateral or bilateral breast
tumours are two primary carcinomas or represent metastatic
spreading of a single neoplastic process is to use a probabilistic
model based on the frequency of genomic imbalances in an
unselected series of cases (Kuukasja ¨rvi et al, 1997). This model
estimates the probability that shared genomic imbalances in two
Figure 2 Comparative genomic hybridisation (A, B) and hierarchical clustering (C) of two bilateral breast carcinomas (case 7) together with other 35
breast carcinomas with copy number changes (coded by chromosome arm). Green bars to the right and red bars to the left of the chromosome ideograms
indicate copy number gains and losses, respectively. See Table 1 for case numbers and a detailed description of the genomic imbalances. The two carcinomas
segregate apart (asterisks), showing that they are pathogenetically more similar to tumours in other women than to one another. This is taken as indication
that these bilateral carcinomas are clonally independent.
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stumours from the same breast cancer patient occur together by
chance alone. Whenever the likelihood that they occur by chance is
less than 0.05, a clonal relationship between two tumours can be
inferred with a probability greater than 0.95. Using these guide-
lines, clonal independence of the separate tumours was inferred in
one of four pairs of ipsilateral breast tumours (25%) and in six of
seven pairs of bilateral breast carcinomas (86%). These findings
are in keeping with our previous findings using chromosome
banding analysis (reviewed in Teixeira et al, 2002).
The probabilistic model predicts that the likelihood that the
shared genetic changes of the two left tumours of patient 12
occurred by chance is only 0.01. Furthermore, in spite of formally
meeting the criteria set for clonal independence, the model
calculates as 0.09 the probability that the shared abnormalities of
the bilateral tumours of patient 6 occurred by chance alone (i.e.,
the likelihood was only slightly above the 0.05 threshold). These
predictions are counterintuitive when one looks at the strikingly
different genomic imbalances harboured by the two lesions. This
indicates that the present model may be inappropriate to
determine the clonal relatedness of tumours with complex
genomes, since the likelihood of detecting several shared genomic
changes just by chance then increases significantly. Additionally,
the probabilistic model was not able to reveal the clonal
relationship between a primary breast carcinoma and its lymph
node metastasis in one of three cases (data not shown), simply
because they shared two of the most common genomic imbalances
in breast cancer (gain of 1q and loss of 16q; X¼0.24, i.e., not
sufficient to meet the 0.05 requirement).
To overcome the above-mentioned limitations, we tested the
possibility of using unsupervised hierarchical clustering of CGH
data to determine more reliably when two tumours are related or
clonally independent. This methodology was able to segregate
correctly three pairs of primary breast carcinomas and their
respective lymph node metastases with widely different genomic
similarity (two of two, four of 11, and 11 of 12 copy number
changes in common). The superiority of hierarchical clustering
probably stems from the fact that it makes use of the entire pattern
of copy number changes, not only the shared ones, present in the
tumours compared. The proper clustering of primary tumours and
their respective metastases took place irrespective of whether the
CGH imbalances were coded by chromosome arm or by
chromosome band. The only discrepancy in the results obtained
by the two coding methods occurred for case 12, in which
clustering of the 26 tumours by chromosome band revealed an
apparent clonal relatedness between the two left tumours. This
finding reveals a pitfall in the use of chromosome bands as data
points, as this puts disproportionate weight on changes affecting
large chromosomes compared with small ones, even if both result
from single events.
Unsupervised hierarchical clustering of CGH data revealed
that multiple, ipsilateral breast tumours were clonally related in
three of four patients, both when the copy number changes
of the tumours of each breast cancer patient were compared with
those of a separate series of 35 breast carcinomas and when
comparison was with the 26 tumours of this series. This finding
confirms our previous conclusion based on chromosome banding
data that most ipsilateral breast tumours arise through intramam-
mary spreading of a single breast cancer (multifocal carcinomas;
Teixeira et al, 1994, 1997). The fact that two of the three multi-
focal carcinomas had carcinoma in situ lesions in both tumours,
and that these were separated by 10–40mm of macroscopi-
cally normal-looking breast tissue, indicated that breast cancer
can spread extensively via the ductal system (Ohtake et al,
1995; Middleton et al, 2002) and illustrates the limitations of
these morphological criteria when it comes to discriminating
multifocal from multicentric breast carcinomas (Dawson, 1993;
Dawson et al, 1995; Tsuda and Hirohashi, 1995; Middleton et al,
2002). One case was classified as multicentric carcinoma by
all the strategies here employed in spite of the fact that the
tumours shared an 8p loss. The relatively high frequency of
8p loss in breast cancer, which makes it a marker of only poor
information value, and the presence of another nine genomic
changes, none of which were shared between the two tumours,
leave little doubt that some ipsilateral tumours are pathogeneti-
cally independent.
The bilateral breast tumours of six of seven patients segregated
apart after hierarchical clustering, indicating that they were
clonally unrelated. This shows that these breast carcinomas were
pathogenetically more similar to carcinomas in other women than
to their contralateral tumours. Of these six patients with two
genetically disparate breast carcinomas, different histological types
were found in two (cases 6 and 9 had a lobular and a ductal
carcinoma; three patients had two ductal carcinomas and the
remaining presented two lobular carcinomas) and carcinoma in
situ components were present in both tumours of five cases, thus
Figure 3 Unsupervised hierarchical clustering of all 26 tumours from the
12 breast cancer patients based on the comparative genomic hybridisation
findings coded by arm. Tumour pairs clustering together represent
spreading of a single disease. Tumour pairs segregating apart are
independent primary carcinomas. See Table 1 for case numbers and a
detailed description of the genomic imbalances.
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ssupporting the conclusion that most patients with bilateral breast
carcinomas have two different diseases (Dawson et al, 1991; Sterns
and Fletcher, 1991; Pandis et al, 1995; Shibata et al, 1996;
Imyanitov et al, 2002). This notwithstanding, one of the patients
presented two bilateral lobular carcinomas sharing all five genomic
imbalances by CGH, strongly arguing that one tumour must have
metastasised to the contralateral breast, as we have also seen
occasionally before (Pandis et al, 1995). We favour this
interpretation over the hypothesis that a common milieu may
have given rise to two clonally independent, but pathogenetically
identical, breast carcinomas (Imyanitov et al, 2002); if this was a
relevant mechanism in breast carcinogenesis, pathogenetically
similar bilateral breast carcinomas should be the rule, not the
exception.
We show that assessment of the clonal relationship among
multiple breast tumours is significantly more informative by
CGH (92% of the individual patients were successfully examined)
than by chromosome banding analysis after short-term culturing
(success rates of between two-thirds and three-fourths of the
cases; Pandis et al, 1995; Teixeira et al, 1997). When the same
cases were analysed by both techniques, discordant conclusions
were obtained in a few of them (Teixeira et al, 1994, 1996, 1997;
Pandis et al, 1995). Clonal selection during in vitro culture
impairing detailed cytogenetic analysis of all tumour cell
subpopulations and CGH failing to detect small clones or balanced
genomic aberrations (Persson et al, 1999; Teixeira et al, 2001;
Kleivi et al, 2002) may contribute to these discrepancies.
We conclude that CGH analysis of multiple breast carcinomas
followed by unsupervised hierarchical clustering of the genomic
imbalances coded by chromosome arm is more effective than
previously used criteria to determine their clonal relationship in
individual patients. To know precisely which ipsilateral or bilateral
breast carcinomas are multiple primaries could help delineate
optimal treatment strategies for these patients as well as identify
families with increased susceptibility to breast cancer.
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